Arginine-deprivation–induced oxidative damage sterilizes Mycobacterium tuberculosis
Author(s) -
Sangeeta Tiwari,
Andries J. van Tonder,
Catherine Vilchèze,
V. Mendes,
S.E. Thomas,
Adel Malek,
Bing Chen,
Mei Chen,
John Kim,
Tom L. Blundell,
Julian Parkhill,
Brian Weinrick,
Michael Berney,
William R. Jacobs
Publication year - 2018
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1808874115
Subject(s) - mycobacterium tuberculosis , arginine , oxidative damage , oxidative phosphorylation , microbiology and biotechnology , oxidative stress , chemistry , tuberculosis , biology , biochemistry , medicine , pathology , amino acid
Significance Tuberculosis results in over 1.7 million deaths annually; this problem is worsened by the emergence of drug-resistant strains. New drugs and a better understanding of the mechanisms of existing interventions are needed to prevent the development of drug resistance. Reactive oxygen species (ROS)-mediated lethality by bactericidal drugs was observed inMycobacterium tuberculosis (Mtb ). Our studies demonstrate that arginine deprivation sterilizes forMtb in vitro and in the host. Using several complementary approaches, we show that arginine deprivation leads to the depletion of thiols, accumulation of ROS, DNA damage, and rapidMtb death. We propose enzymes in the de novo arginine biosynthesis pathway represent promising drug target candidates to be inhibited to treatMtb and its drug-resistant strains.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom